期刊文献+

染料木素等5种黄酮类物质对小鼠血清尿酸水平及黄嘌呤氧化酶活性的影响

Effects of genistein in five different flavonoid compounds on xanthine oxidase activities and serum uric acid levels in mice
下载PDF
导出
摘要 目的探讨黄酮类化合物染料木素、芹菜素、槲皮素、芦丁和落新妇苷体外对黄嘌呤氧化酶活性的影响,对正常小鼠血清和肝脏黄嘌呤氧化酶活性的影响,同时评价对小鼠血清尿酸水平的作用。方法采用改良的紫外分光光度法测定染料木素、芹菜素、槲皮素、芦丁和落新妇苷体外对黄嘌呤氧化酶的抑制作用,采用分光光度法研究对小鼠血清和肝脏黄嘌呤氧化酶活性的影响,以磷钨酸法测定对小鼠血清尿酸水平的作用。结果体外实验表明黄酮类化合物染料木素、芹菜素、槲皮素、芦丁和落新妇苷体外对黄嘌呤氧化酶活性无明显影响。体内实验观察到这5种黄酮类化合物能够显著升高或降低黄嘌呤氧化酶的活性;而且,血清尿酸水平与血清黄嘌呤氧化酶活性密切相关,与肝脏黄嘌呤氧化酶活性无明显关联。用这些黄酮类化合物给药的小鼠血清尿酸水平都高于正常对照组。结论这5种黄酮类化合物不能够作为替代别嘌醇的药物用来降低血清尿酸水平。 Objective To investigate the effects of the flavonoids genistein, apigenin, quercetin, rutin and astilbin on xanthine oxidase (XO) activities in vitro, and in serum and liver. To measure the effects of the flavonoids on serum uric acid levels in vivo. Methods The inhibitory effects of genistein, apigenin, quercetin, rutin and astilbin on in vitro xanthine oxidase activity were determined using a modified spectrophotometfic method. The XO activity in serum and liver were determined spectrophotometrically using standard diagnostic kits;meanwhile, serum uric acid levels were determined using the phosphotungstic acid method. Results In vitro studies indicated that the flavonoids tested did not significantly affect XO activity. However, signifi- cant increases and decreases in XO activities were observed in vivo. Moreover, serum XO activity was correlated with serum uric acid levels, while no correlation was observed for liver XO activity. The present study showed that serum uric acid levels in mice treated with the flavonoids tested here are higher than control levels. Conclusions The tested flavonoids cannot be the candidates to replace allopurinol as a treatment to reduce serum uric acid levels.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第9期721-726,共6页 Journal of Shenyang Pharmaceutical University
关键词 染料木素 芹菜素 槲皮素 芦丁 落新妇苷 高尿酸血症 黄嘌呤氧化酶 genistein apigenin quercetin rutin astilbin hyperuricemia xanthine oxidase
  • 相关文献

参考文献19

  • 1RODDY E, ZHANG W, DOHERTY M. The changing epidemiology of gout E J ]. Nat Clin Pract Rheumatol, 2007,3(8) :443 -449.
  • 2WU E Q, PATEL P A, YU A P, et al. Disease-related and all-cause health care costs of elderly patients with gout[J].J Manag Care Pharm,2008,14(2):164 - 175.
  • 3SHORT R A, TUTTLE K R. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease:a statistical modeling perspective [J]. Semin Nephrol,2005,25 ( 1 ) : 25 - 31.
  • 4HEINIG M, JOHNSON R J. Role of uric acid in hypertension, renal disease, and metabolic syndrome I J ]. Cleve Clin J Med,2006,73 (12) : 1059 - 1064.
  • 5CHOI H K, FORD E S. Prevalence of the metabolic syndrome in individuals with hyperudcemiaE J ]. Am J Med,2007,120 (5) :442 - 447.
  • 6TERKELTAUB R A. Clinical practice, Gout [ J ]. N Engl J Med,2003,349 ( 17 ) : 1647 - 1655.
  • 7RAMALLO I A, ZACCHINO S A, FURLAN R L. A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers [ J ]. Phytochem Anal,2006,17 ( 1 ) : 15 - 19.
  • 8UNNO T, SUGIMOTO A, KAKUDA T. Xanthine oxidase inhibitors from the leaves of Lagerstroemia spe- ciosa( L ) Pers [ J ]. J Ethnopharrnacol, 2004,93 ( 2/ 3) :391 -395.
  • 9LIN Chun-mao, CHEN Chien-shu, CHEN Chien-tsu, et al. Molecular modeling of flavonoids that inhibits xanthine oxidase[J]. Biochem Biophys Res Commun, 2002,294(1) :167 - 172.
  • 10VAN HOORN D E, NIJVELDT R J, VAN LEEUWEN P A, et al. Accurate prediction of xanthine oxi- dase inhibition based on the structure of flavonoids [J]. Eur J Pharmacol,2002,451 (2) :111 - 118.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部